Biological Assembly 1  

 3D View: Structure | Electron Density | Ligand Interaction

Standalone Viewers  
Protein Workshop | Ligand Explorer

Global Symmetry: Asymmetric - C1 
Global Stoichiometry: Monomer - A 

Biological assembly 1 assigned by authors.

Macromolecule Content

• Total Structure Weight: 38269.19 
• Atom Count: 2540 
• Residue Count: 333 
• Unique protein chains: 1

1M17

Epidermal Growth Factor Receptor tyrosine kinase domain with 4-anilinoquinazoline inhibitor erlotinib

• DOI: 10.2210/pdb1M17/pdb

• Classification: TRANSFERASE
• Organism(s): Homo sapiens
• Expression System: Spodoptera frugiperda


• Deposited: 2002-06-17 Released: 2002-09-04 
• Deposition Author(s): Stamos, J., Sliwkowski, M.X., Eigenbrot, C.

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 2.6 Å
• R-Value Free: 0.295 
• R-Value Work: 0.251 

Literature

Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor.

Stamos, J., Sliwkowski, M.X., Eigenbrot, C.

(2002) J.Biol.Chem. 277: 46265-46272

• PubMed: 12196540 
• DOI: 10.1074/jbc.M207135200
• Primary Citation of Related Structures:  
  1M14


• PubMed Abstract: 
  

The crystal structure of the kinase domain from the epidermal growth factor receptor (EGFRK) including forty amino acids from the carboxyl-terminal tail has been determined to 2.6-A resolution, both with and without an EGFRK-specific inhibitor currently in Phase III clinical trials as an anti-cancer agent, erlotinib (OSI-774, CP-358,774, Tarceva(TM)). The EGFR family members are distinguished from all other known receptor tyrosine kinases in possessing constitutive kinase activity without a phosphorylation event within their kinase domains. Despite its lack of phosphorylation, we find that the EGFRK activation loop adopts a conformation similar to that of the phosphorylated active form of the kinase domain from the insulin receptor. Surprisingly, key residues of a putative dimerization motif lying between the EGFRK domain and carboxyl-terminal substrate docking sites are found in close contact with the kinase domain. Significant intermolecular contacts involving the carboxyl-terminal tail are discussed with respect to receptor oligomerization.

---

Organizational Affiliation: 

Department of Protein Engineering, Genentech, Inc., South San Francisco, California 94080, USA.

Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details
epidermal growth factor receptor	A	333	Homo sapiens	Mutation(s): 0  Gene Names: EGFR (ERBB, ERBB1, HER1) EC: 2.7.10.1
Find proteins for P00533 (Homo sapiens) Go to Gene View: EGFR Go to UniProtKB:  P00533

Small Molecules

Ligands 1 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram & Interactions
AQ4	A	[6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE ERLOTINIB C22 H23 N3 O4 AAKJLRGGTJKAMG-UHFFFAOYSA-N

External Ligand Annotations
ID	Binding Affinity (Sequence Identity %)
AQ4	IC50: 0 - 260 nM (100) BINDINGDB
AQ4	Kd: 0.3 - 1600 nM (100) BINDINGDB
AQ4	Ki: 0.1 nM (100) BINDINGDB

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 2.6 Å
• R-Value Free: 0.295 
• R-Value Work: 0.251 
• Space Group: I 2 3

Unit Cell:

Length (Å)	Angle (°)
a = 147.800	α = 90.00
b = 147.800	β = 90.00
c = 147.800	γ = 90.00

Software Package:

Software Name	Purpose
DENZO	data reduction
AMoRE	phasing
CCP4	data scaling
TRUNCATE	data reduction
X-PLOR	refinement

Structure Validation

Entry History 

Deposition Data

• Deposited Date: 2002-06-17 
• Released Date: 2002-09-04 
• Deposition Author(s): Stamos, J., Sliwkowski, M.X., Eigenbrot, C.

Revision History 

• Version 1.0: 2002-09-04
  Type: Initial release
• Version 1.1: 2008-04-28
  Type: Version format compliance
• Version 1.2: 2011-07-13
  Type: Version format compliance